Effects of cilomilast, a selective phosphodiesterase 4 inhibitor, on esophageal motility and ph, and orocecal and colonic transit: Two single-center, randomized, double-blind, placebo-controlled, two-part crossover studies in healthy volunteers
Houghton, Lesley A., Atkinson, Wendy, Whorwell, Peter J., Morris, Julie, Murdoch, Robert D., Cooper, Stephen M., Webber, Dawn M., Walls, Christine M.
Published in Clinical therapeutics (01.04.2006)
Published in Clinical therapeutics (01.04.2006)
Get full text
Journal Article
An overview of the pharmacokinetics of cilomilast (Ariflo), a new, orally active phosphodiesterase 4 inhibitor, in healthy young and elderly volunteers
Zussman, B D, Benincosa, L J, Webber, D M, Clark, D J, Cowley, H, Kelly, J, Murdoch, R D, Upward, J, Wyld, P, Port, A, Fuder, H
Published in Journal of clinical pharmacology (01.09.2001)
Published in Journal of clinical pharmacology (01.09.2001)
Get more information
Journal Article
Warfarin pharmacodynamics unaffected by cilomilast
Kelly, J, Murdoch, R D, Clark, D J, Webber, D M, Fuder, H
Published in The Annals of pharmacotherapy (01.12.2001)
Published in The Annals of pharmacotherapy (01.12.2001)
Get more information
Journal Article